v3.26.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Stock Options A summary of the Company’s stock option activity for its Plans is as follows:
Outstanding
Stock Options
(in thousands)
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Life
(in years)
Aggregate
Intrinsic Value
(in millions)
Balance as of December 31, 20251
4,786 $11.58 7.2$13.4 
Granted
581 $10.18 
Exercised(73)$3.90 
Cancelled/forfeited
(1)$2.50 
Balance as of March 31, 20261
5,293 $11.53 7.3$4.0 
Vested and exercisable as of March 31, 2026
2,770 $12.46 5.6$2.3 
______________
(1)Includes 0.2 million of stock options with both service-based and performance-based conditions.
Schedule of Weighted-Average Assumptions and Ranges of Fair Value of Common Stock
The per-share fair value of each stock option granted was determined on the date of grant using the following weighted-average assumptions:
Three Months Ended
March 31,
20262025
Expected volatility58.9%57.7%
Expected term (in years)6.16.0
Risk-free interest rate4.0%4.2%
Schedule of Outstanding Nonvested RSUs A summary of the Company’s outstanding nonvested RSUs for its Plans is as follows:
Number of Units
(in thousands)
Weighted-Average
Grant-Date
Fair Value
Nonvested as of December 31, 20251
5,070 $11.13 
Granted
724 $10.27 
Vested1
(411)$11.79 
Forfeited
(123)$11.01 
Nonvested as of March 31, 20261
5,260 $10.97 
______________
(1)Includes less than 0.1 million of RSUs with both service-based and performance-based conditions.
Schedule of Stock-based Compensation Expense The Company recognized stock-based compensation under the Plans and ESPP as follows:
Three Months Ended
March 31,
(in millions)20262025
Research and development$1.9 $2.1 
Sales and marketing2.2 2.1 
General and administrative2.9 2.5 
Total Stock-based Compensation
$7.0 $6.7